Helena Laboratories: FDA filings under this applicant name
FDA lists 282 510(k) clearances under 2 spellings of the applicant name “Helena Laboratories” (first 1978, latest 2022), across 83 product codes in 4 review panels. Median 510(k) review time under this name: 56 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 1 | 138 |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 2 | 638 |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Helena Laboratories took a median 638 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 198 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| LCP | Assay, Glycosylated Hemoglobin | 19 | 19 |
| GGP | Test, Qualitative And Quantitative Factor Deficiency | 17 | 17 |
| CEF | Electrophoretic, Protein Fractionation | 15 | 15 |
| JHO | Electrophoretic Separation, Lipoproteins | 15 | 15 |
| KHE | Reagent, Occult Blood | 12 | 12 |
| CFE | Electrophoretic, Lactate Dehydrogenase Isoenzymes | 11 | 11 |
| JBD | System, Analysis, Electrophoretic Hemoglobin | 11 | 11 |
| JJY | Multi-Analyte Controls, All Kinds (Assayed) | 11 | 11 |
| JJN | Apparatus, Electrophoresis, For Clinical Use | 8 | 8 |
| JPA | System, Multipurpose For In Vitro Coagulation Studies | 8 | 8 |
Plus 73 more product codes.
Review panels
- Hematology (136)
- Clinical Chemistry (120)
- Immunology (23)
- Pathology (3)
Most recent Helena Laboratories 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K213396 | SPIFE A1AT kit | OBZ | 2022-10-13 | 360 |
| K192931 | V8 Nexus Hemoglobin Ultrascreen, V8 AFSA2 Hemo Control | GKA | 2022-04-19 | 915 |
| K131479 | V8 SP NORMAL CONTROL, ABNORMAL CONTROL | JJY | 2013-10-07 | 138 |
| K100103 | SPECIALTY ASSAYED CONTROL-2 | GGC | 2010-12-15 | 336 |
| K061991 | PLATELETWORKS ARACHIDONIC ACID, MODEL PW-ACA | GHR | 2007-02-23 | 225 |
| K061069 | SPIFE IFE-15 PENTAVALENT, MODEL 3456, SPIFE IFE-9 PENTAVALENT KIT, MODEL 3457, SPIFT IFE-6 PENTAVALENT KIT, MODEL 3458 | CFF | 2006-07-06 | 80 |
| K061014 | ACTALYKE QC KIT, MODELS AQC-HP AND AQC-LP | JPA | 2006-05-10 | 27 |
| K050053 | HEMORAM/AGGRAM ANALYZER | JPA | 2005-07-11 | 182 |
| K024162 | SPIFE 3000 TITAN GEL IGG IEF KIT, MODEL 3389 | CFF | 2003-02-19 | 64 |
| K023761 | PLATELETWORKS, MODELS PW-A, PW-C | JOZ | 2003-02-14 | 98 |
272 earlier clearances. See the full list in Caduvo.
Recalls
16 product recalls in 14 recall events; 2 initiated in the last five years. Most recent: 2023-05-02.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Helena Laboratories (a text match, not an official crosswalk):
- J7197 — Antithrombin iii (human), per i.u. (via JBQ)
- J1460 — Injection, gamma globulin, intramuscular, 1 cc (via DAH)
- J7213 — Injection, coagulation factor ix (recombinant), ixinity, 1 i.u. (via GJT)
- J1560 — Injection, gamma globulin, intramuscular, over 10 cc (via DAH)
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Helena Laboratories (280)
- Helena Laboratories, Corp. (2)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Helena Laboratories Uk, Ltd. (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Helena Laboratories?
FDA lists 282 510(k) clearances under 2 spellings of the applicant name “Helena Laboratories” (first 1978, latest 2022), across 83 product codes in 4 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Helena Laboratories?
The median time from FDA receipt to decision across 510(k)s cleared under the name Helena Laboratories is 56 days.
Which FDA product codes appear under Helena Laboratories?
The most frequent FDA product codes under this applicant name are LCP (Assay, Glycosylated Hemoglobin, 19); GGP (Test, Qualitative And Quantitative Factor Deficiency, 17); CEF (Electrophoretic, Protein Fractionation, 15).
Next steps
- See all 282 Helena Laboratories clearances with predicates and recalls
- Run predicate analysis for product code LCP, Helena Laboratories's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.